The FDA has started its review of a subcutaneous injection formulation ... rather than in an infusion clinic. Eisai and Biogen's filing is for a once-weekly autoinjector formulation of Leqembi ...

TG Therapeutics is entering 2025 with investors accustomed to a beat-and-raise guidance policy and the company needs to ...

An ustekinumab biosimilar to Stelara launched in France, completing its rollout across 5 major European markets and paving ...

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

Recent research has focused on improving the performance and longevity of insulin infusion sets, which are crucial components of CSII systems. These studies have explored various factors ...

This important study assessed the effects of food intake on sharp wave-ripples in the hippocampus of mice during subsequent sleep. Solid evidence supports the conclusion that sharp wave-ripples are ...

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version ... rather than by intravenous infusion. That could make it possible ...

Lecanemab is the result of a strategic research alliance between BioArctic and Eisai. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatmentAlzheimer's disease progression does ...

The FDA has accepted the BLA for lecanemab-irmb SC for weekly maintenance dosing in the treatment of early Alzheimer disease.

Wizards of the Coast has released 168 MTG sets over the game’s 32-year history: an average of five new sets per year. To help you keep track, and to provide a full timeline that goes right back to the ...